Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engagement of ILT2/CD85j in Sézary syndrome cells inhibits their CD3/TCR signaling
Maria Nikolova, Philippe Musette, M. Bagot, et al.
Blood (2002) Vol. 100, Iss. 3, pp. 1019-1025
Closed Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Negative Regulation of T Cell Receptor Signaling by Siglec-7 (p70/AIRM) and Siglec-9
Yuzuru Ikehara, Sanae Ikehara, James C. Paulson
Journal of Biological Chemistry (2004) Vol. 279, Iss. 41, pp. 43117-43125
Closed Access | Times Cited: 197
Aberrant Expression of the Tyrosine Kinase Receptor EphA4 and the Transcription Factor Twist in Sézary Syndrome Identified by Gene Expression Analysis
Remco van Doorn, Remco Dijkman, Maarten H. Vermeer, et al.
Cancer Research (2004) Vol. 64, Iss. 16, pp. 5578-5586
Closed Access | Times Cited: 168
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer
Tobias Zeller, Ira A. Münnich, Roland Windisch, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Lack of T-Cell Receptor–Induced Signaling Is Crucial for CD95 Ligand Up-regulation and Protects Cutaneous T-Cell Lymphoma Cells from Activation-Induced Cell Death
Claus‐Detlev Klemke, Dirk Brenner, Eva-Maria Weiβ, et al.
Cancer Research (2009) Vol. 69, Iss. 10, pp. 4175-4183
Open Access | Times Cited: 57
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Christoph Hieber, Stephan Grabbe, Matthias Bros
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1085-1085
Open Access | Times Cited: 11
Specific Recognition of the Viral Protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T Cells Mediates the Non-MHC-Restricted Lysis of Human Cytomegalovirus-Infected Cells
Danièle Saverino, Fabio Ghiotto, Andrea Merlo, et al.
The Journal of Immunology (2004) Vol. 172, Iss. 9, pp. 5629-5637
Open Access | Times Cited: 63
Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies
Jilu Zhang, Sunny Mai, Hui-Ming Chen, et al.
Journal of Leukocyte Biology (2017) Vol. 102, Iss. 2, pp. 351-360
Open Access | Times Cited: 39
Immunoglobulin-like transcript 4 promotes tumor progression and metastasis and up-regulates VEGF-C expression via ERK signaling pathway in non-small cell lung cancer
Pei Zhang, Xiaosun Guo, Juan Li, et al.
Oncotarget (2015) Vol. 6, Iss. 15, pp. 13550-13563
Open Access | Times Cited: 37
Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2
Mirjana Urosevic, Jivko Kamarashev, Günter Burg, et al.
Blood (2003) Vol. 103, Iss. 5, pp. 1796-1798
Open Access | Times Cited: 52
CD85j (Leukocyte Ig-Like Receptor-1/Ig-Like Transcript 2) Inhibits Human Osteoclast-Associated Receptor-Mediated Activation of Human Dendritic Cells
Claudya Tenca, Andrea Merlo, Estelle Merck, et al.
The Journal of Immunology (2005) Vol. 174, Iss. 11, pp. 6757-6763
Open Access | Times Cited: 48
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma
Ester Lozano, Tania Díaz, Mari-Pau Mena, et al.
The Journal of Immunology (2018) Vol. 200, Iss. 8, pp. 2581-2591
Open Access | Times Cited: 25
Killer Cell Ig-Like Receptor-Dependent Signaling by Ig-Like Transcript 2 (ILT2/CD85j/LILRB1/LIR-1)
Sheryl Kirwan, Deborah N. Burshtyn
The Journal of Immunology (2005) Vol. 175, Iss. 8, pp. 5006-5015
Open Access | Times Cited: 32
Therapeutic Antibodies to KIR3DL2 and Other Target Antigens on Cutaneous T-Cell Lymphomas
Christian Schmitt, Anne Marie‐Cardine, Armand Bensussan
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 20
Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients
Alix Jacquier, Tiphaine Lambert, Jean-François Delattre, et al.
Cancer Letters (2021) Vol. 519, pp. 105-116
Open Access | Times Cited: 14
HLA‐G inhibition of NK‐cell cytolytic function is uncoupled from tumor cell lipid raft reorganization
Jérémy Baudhuin, Emilie Lesport, Sylvie Sousa, et al.
European Journal of Immunology (2011) Vol. 42, Iss. 3, pp. 700-709
Open Access | Times Cited: 17
Sézary Syndrome, recent biomarkers and new drugs
Cristina Cristofoletti, Maria Grazia Narducci, Giandomenico Russo
Chinese Clinical Oncology (2018) Vol. 8, Iss. 1, pp. 2-2
Open Access | Times Cited: 15
Correlation between MDSC and Immune Tolerance in Transplantation: Cytokines, Pathways and Cell-cell Interaction
Tianying Yang, Jiawei Li, Ruimin Li, et al.
Current Gene Therapy (2019) Vol. 19, Iss. 2, pp. 81-92
Closed Access | Times Cited: 14
Cellular Coincidence of Clonal T Cell Receptor Rearrangements and Complex Clonal Chromosomal Aberrations—A Hallmark of Malignancy in Cutaneous T Cell Lymphoma
J. Marcus Muche, Leena Karenko, Sylke Gellrich, et al.
Journal of Investigative Dermatology (2004) Vol. 122, Iss. 3, pp. 574-578
Open Access | Times Cited: 23
New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas
Claus‐Detlev Klemke, Sergij Goerdt, David Schrama, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2006) Vol. 4, Iss. 5, pp. 395-405
Closed Access | Times Cited: 21
HLA-G in skin cancer: a wolf in sheep's clothing?
Mirjana Urosevic, Reinhard Dummer
Human Immunology (2003) Vol. 64, Iss. 11, pp. 1073-1080
Closed Access | Times Cited: 19
Immunopathogenesis of cutaneous T-cell lymphomas
Martine Bagot, Laurence Boumsell, Armand Bensussan
Hematology/Oncology Clinics of North America (2003) Vol. 17, Iss. 6, pp. 1313-1317
Closed Access | Times Cited: 15
Expression of activating natural killer‐cell receptors is a hallmark of the innate‐like T‐cell neoplasm in peripheral T‐cell lymphomas
Yu Uemura, Yasushi Isobe, Akiko Uchida, et al.
Cancer Science (2018) Vol. 109, Iss. 4, pp. 1254-1262
Open Access | Times Cited: 8
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
Alan W. Hodges, Rachel Dubuque, Shu‐Hsia Chen, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Les lymphomes T épidermotropes comme modèles de progression tumorale
M. Bagot, Armand Bensussan
(2006) Vol. 22, Iss. 2, pp. 192-196
Closed Access | Times Cited: 2
Les lymphomes T épidermotropes comme modèles de progression tumorale
M. Bagot, Armand Bensussan
médecine/sciences (2006) Vol. 22, Iss. 2, pp. 192-196
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top